Skip to main content
. Author manuscript; available in PMC: 2014 Sep 15.
Published in final edited form as: Cancer Immunol Immunother. 2011 Dec 24;61(7):1125–1136. doi: 10.1007/s00262-011-1187-z

Fig. 2.

Fig. 2

PR3 and ELA2 gene expression in the peripheral blood of patients with CML, ALL, and solid tumor after SCT. a Correlation between PR3 and ELA2 expression in PB samples from the patients with CML, ALL, and solid tumor. b ELA2 gene expression in peripheral blood samples from the patients with CML, ALL, and solid tumor after SCT. Bars represent medians. Values of genes represent the RQ-PCR expression as a ratio of the gene of interest to the ABL control gene